Table 1.
Comparison of clinical and outcome features of patients with PCM with or without HIV infection
| Clinical data | PCM HIV+ | PCM HIV− | OR (95% CI) | P value | |
|---|---|---|---|---|---|
| N (%) | N (%) | ||||
| Fever | Yes | 21 (67.8) | 25 (39.1) | 3.28 (1.33–8.10) | 0.010 |
| No | 10 (32.2) | 39 (60.9) | 1.00 | ||
| Weight loss | Yes | 20 (64.5) | 31 (48.4) | 1.94 (0.80–4.69) | 0.143 |
| No | 11 (35.5) | 33 (51.6) | 1.00 | ||
| Respiratory symptoms | Yes | 16 (51.6) | 32 (50) | 1.07 (0.45–2.52) | 0.883 |
| No | 15 (48.4) | 32 (50) | 1.00 | ||
| Mucosal involvement | Yes | 10 (32.2) | 37 (57.8) | 0.35 (0.14–0.86) | 0.022 |
| No | 21 (67.8) | 27 (42.2) | 1.00 | ||
| Lymph node enlargement | Yes | 17 (54.8) | 36 (56.3) | 0.57 (0.23–1.43) | 0.232 |
| No | 14 (45.2) | 17 (56.7) | 1.00 | ||
| Skin lesions | Yes | 13 (41.9) | 26 (40.6) | 1.06 (0.44–2.52) | 0.903 |
| No | 18 (58.1) | 38 (59.4) | 1.00 | ||
| Clinical forms | Acute | 19 (61.2) | 15 (21.9) | 5.17 (2.05–13.05) | < 0.001 |
| Chronic | 12 (38.7%) | 49 (75.0%) | 1.00 | ||
| Outcome | Cured | 15 (55.5%) | 20 (50%) | 1.07 (0.42–2.79) | 0.213 |
| Relapsed | 4 (14.8%) | 12 (30%) | 1.00 (Relapsed + died) | ||
| Died | 10 (32.2%) | 8 (20.0%) | |||
CI = confidence interval; HIV = human immunodeficiency virus; OR = odds ratio; PCM = paracoccidioidomycosis. The bold values indicated the statistical significant values.